Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Sinnar Bidi Udyog Ltd

SINNAR
BSE
685.00
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Sinnar Bidi Udyog Ltd

SINNAR
BSE
685.00
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
27Cr
Close
Close Price
685.00
Industry
Industry
Chewing Tobacco/Pan Masala
PE
Price To Earnings
138.95
PS
Price To Sales
5.77
Revenue
Revenue
5Cr
Rev Gr TTM
Revenue Growth TTM
-4.81%
PAT Gr TTM
PAT Growth TTM
-195.00%
Peer Comparison
How does SINNAR stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
SINNAR
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
111111111121
Growth YoY
Revenue Growth YoY%
-11.1-43.8-15.8-29.2-3.152.3-35.622.3-21.0-9.977.1-39.9
Expenses
ExpensesCr
111111111111
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
-12.5-9.35.48.3-12.1-13.0-3.13.4-4.10.014.7-9.0
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
000000000000
Growth YoY
PAT Growth YoY%
2,600.0-57.136.4200.0-144.0-566.7-113.316.763.6150.01,250.0-200.0
NPM
NPM%
19.53.510.15.0-8.9-10.7-2.14.7-4.15.913.5-7.9
EPS
EPS
6.20.73.71.5-2.8-3.5-0.51.9-0.91.85.8-1.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
109865556555
Growth
Revenue Growth%
-13.4-8.4-30.4-1.4-6.31.420.9-23.6-1.40.4
Expenses
ExpensesCr
98855556555
Operating Profit
Operating ProfitCr
11000000000
OPM
OPM%
10.45.82.62.90.3-1.9-3.2-3.2-1.6-4.12.7
Other Income
Other IncomeCr
00000001000
Interest Expense
Interest ExpenseCr
10000000000
Depreciation
DepreciationCr
00000000000
PBT
PBTCr
00000000000
Tax
TaxCr
00000000000
PAT
PATCr
00000000000
Growth
PAT Growth%
-98.2-3,611.7-49.2-9.923.230.3461.4-72.9-203.7253.0
NPM
NPM%
2.10.1-1.8-3.7-4.2-3.4-2.47.02.5-2.64.0
EPS
EPS
10.80.2-7.0-10.4-5.7-4.4-3.011.13.0-3.14.9

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
00000000000
Reserves
ReservesCr
44444444445
Current Liabilities
Current LiabilitiesCr
63332432110
Non Current Liabilities
Non Current LiabilitiesCr
22533333333
Total Liabilities
Total LiabilitiesCr
13101210910109998
Current Assets
Current AssetsCr
1191198898887
Non Current Assets
Non Current AssetsCr
11111211111
Total Assets
Total AssetsCr
13101210910109998

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
13-2203-1-14-1
Investing Cash Flow
Investing Cash FlowCr
00000-11100
Financing Cash Flow
Financing Cash FlowCr
-2-32-20-20000
Net Cash Flow
Net Cash FlowCr
000000004-1
Free Cash Flow
Free Cash FlowCr
13-2203-104-1
CFO To PAT
CFO To PAT%
664.372,323.71,495.5-1,058.3-47.0-1,562.1613.8-173.43,121.91,029.7
CFO To EBITDA
CFO To EBITDA%
137.8566.3-1,016.71,369.0718.8-2,793.1449.8378.7-4,844.6661.6

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
000090091929
Price To Earnings
Price To Earnings
0.00.00.00.00.00.00.019.5155.20.0
Price To Sales
Price To Sales
0.00.00.00.01.60.00.01.43.96.2
Price To Book
Price To Book
0.00.00.00.02.10.00.02.04.16.6
EV To EBITDA
EV To EBITDA
3.62.517.210.3693.70.70.4-42.3-188.1-135.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
27.523.825.836.034.423.727.527.428.232.0
OPM
OPM%
10.45.82.62.90.3-1.9-3.2-3.2-1.6-4.1
NPM
NPM%
2.10.1-1.8-3.7-4.2-3.4-2.47.02.5-2.6
ROCE
ROCE%
10.87.82.22.0-0.2-2.5-3.310.94.5-3.2
ROE
ROE%
4.70.1-3.0-4.7-5.5-4.4-3.210.22.7-2.8
ROA
ROA%
1.70.0-1.1-2.1-2.5-1.7-1.24.71.4-1.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Sinnar Bidi Udyog Limited is an Indian-domiciled entity historically rooted in the tobacco industry. The company is currently navigating a significant strategic pivot, transitioning from an active manufacturing and trading operation toward a holding and investment-focused structure, while simultaneously pursuing a voluntary delisting from the **BSE Limited**. --- ### **Strategic Transition: Voluntary Delisting & Private Consolidation** The company is currently undergoing a formal **Voluntary Delisting** process initiated by its promoters to consolidate ownership and exit the public markets. * **Rationale for Delisting:** The promoters (**Acquirers**) aim to obtain **100%** control to enhance **operational flexibility**. This move is intended to eliminate the high costs of regulatory compliance, listing fees, and administrative burdens associated with being a listed entity, allowing management to focus on business operations rather than stock exchange requirements. * **The Offer Terms:** In **June 2024**, the company received an **Initial Public Announcement (IPA)**. The **Floor Price** has been set at **₹ 335/-** per Equity Share (Face Value **₹ 5/-**). * **Key Stakeholders:** The primary **Acquirers** are **Rasbihari Enterprises Private Limited** and **Mr. Shrirang Kisanlal Sarda**. **Vivro Financial Services Private Limited** is acting as the Manager to the Offer. * **Success Criteria:** Under **SEBI (Delisting of Equity Shares) Regulations, 2021**, the delisting is successful only if the promoters' shareholding reaches a **90%** threshold and a Special Resolution is passed where votes in favor are at least **2x** the votes against. --- ### **Core Business Operations & Market Challenges** The company’s business model is centralized under a single vertical: the **Manufacturing, Trading, and Processing** of tobacco and tobacco products. * **Revenue & Profitability Pressures:** The company has experienced a consistent **decrease** in sales turnover across **FY 2023-24** and **FY 2024-25**. Profitability is severely constrained by rising **tobacco costs**, leading to recurring operational losses. * **Asset-Dependent Earnings:** In recent years, net profits have been largely artificial, supported by the **sale of fixed assets** rather than core tobacco processing activities. * **Regulatory Barriers:** Management identifies **stringent government regulations** as the primary obstacle to expansion. Consequently, the Board has recommended **no dividend** for the last three financial years to conserve capital. * **Geographic Footprint:** * **Registered Office:** Recently relocated to **Andheri, Mumbai** (Office No 804, Mahal Industrial Estate). * **Administrative Office:** Maintained at **"Camel House"**, Nashik-Pune Road, Nashik. --- ### **Financial Position & Capital Structure** Sinnar Bidi Udyog operates with a lean capital base, qualifying for specific exemptions under **SEBI (LODR) Regulation 15 (2)** due to its low paid-up capital. | Metric | FY 2024-25 (As of 31.03.2025) | FY 2023-24 (As of 31.03.2024) | | :--- | :--- | :--- | | **Paid-up Equity Share Capital** | **₹ 20.00 Lakhs** | **₹ 20.00 Lakhs** | | **Net Worth** | **₹ 4.39 Crore** | - | | **Share of Profit from Associates** | **₹ 0.13 Lakhs** | **₹ 7.25 Lakhs** | * **Investment Portfolio:** The company maintains interests in associate companies but has no subsidiaries or joint ventures. * **Vidarbha Bidi Limited** (Associate) * **Tip Top Health Zone Private Limited** (Associate) * **Yogi Ayurvedic Products Private Limited** (Investment via STS Exports amalgamation) --- ### **Legacy Liabilities & Risk Factors** The company’s financial health is significantly impacted by historical liabilities stemming from past tobacco exports to the United States. * **US Escrow Deposit Liability:** Under US law, the company must deposit funds into an **Escrow Fund** based on historical tobacco sales. This remains a major provision on the balance sheet. * **Foreign Exchange Exposure:** While there are no active foreign exchange earnings, the company reports **Foreign Exchange Losses** (e.g., **₹ 7.46 Lakhs** in FY25) due to the restatement of the USD-denominated escrow liability. **Escrow Fund Provisioning Trends:** | Particulars | March 31, 2025 | March 31, 2024 | March 31, 2023 | | :--- | :--- | :--- | :--- | | **Total Provision for Escrow** | **₹ 289.04 Lakhs** | **₹ 281.59 Lakhs** | **₹ 278.15 Lakhs** | | **FX Loss (Restatement)** | **₹ 7.46 Lakhs** | **₹ 3.43 Lakhs** | **₹ 20.86 Lakhs** | | **Fresh Demands** | **Nil** | **Nil** | **Nil** | * **Solvency Concerns:** Auditors have noted that while the company can meet liabilities due within **one year**, there is no long-term assurance regarding **future viability** or the ability to discharge liabilities beyond the immediate **12-month** horizon. --- ### **Governance & Management Framework** The company adheres to **Indian Accounting Standards (Ind AS)** and maintains a stable leadership team to oversee the delisting and liability management. * **Key Leadership:** * **Mr. Ramdas Prabhakar Jadhav:** Re-appointed as **Whole Time Director & CFO** for a three-year term starting **April 1, 2025**. * **Ms. Aditi Shah:** Appointed as **Additional Director (Independent & Non-Executive)** for a **5-year** term effective **June 1, 2025**. * **Regulatory Compliance:** * The company has assessed the **New Labour Codes** (effective **November 21, 2025**) and determined that no additional financial provisions are required at this stage. * Due to its small size, it is exempt from filing **Annual Secretarial Compliance Reports** and **Regulation 23(9)** related party disclosures. * **Audit Oversight:** Due diligence for the delisting process is conducted by **M/s. A.K. Jain & Associates** (Peer Review Company Secretary).